AEON · AEON Biopharma Inc
United States · RS rating 10 · As of 2026-11-03
| Price | 0.21 USD |
|---|---|
| 1-day change | -22.3% |
| RS rating (overall / 1M / 3M / 12M) | 10 / 20 / 24 / 11 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 22 / 16 / 21 |
| Industry group (rank) | Medical-Biomed/Biotech (154) |
| EPS growth Q/Q | +93.1% |
| Sales growth Q/Q | – |
| Distance from 52-week high | +84.4% |
| Market cap (USD) | $26.3M |